Get started
Author

Esteban Burrone

Observed names: Burrone, Esteban, E. Burrone
ORCID: 0000-0001-7554-2064
Observed ORCID: 0000-0001-7554-2064
OpenAlex ID: A5064577395
Access to Treatment for Hepatitis B Virus Infection — Worldwide, 2016
2018 · Yvan Hutin, Muazzam Nasrullah, et al. · MMWR Morbidity and Mortality Weekly Report · 127
PDF
Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities
2022 · Sébastien Morin, Giulia Segafredo, et al. · The Lancet Global Health · 70
Patent pooling to increase access to essential medicines
2019 · Esteban Burrone, Dzintars Gotham, et al. · Bulletin of the World Health Organization · 50
PDF
Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries
2024 · Shelly Malhotra, Anne-Isabelle Cameron, et al. · PLOS Global Public Health · 31
Intellectual Property Rights and Innovation in SMEs in OECD Countries
2005 · Esteban Burrone · 29
Access to treatment for hepatitis B virus infection—Worldwide, 2016
2018 · Yvan Hutin, Muazzam Nasrullah, et al. · American Journal of Transplantation · 24
Affordability of new HIV treatments
2014 · Esteban Burrone, Greg Perry · The Lancet · 20
PDF
NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions
2020 · Mariachiara Di Cesare, Jordan D. Jarvis, et al. · Global Heart · 13
PDF
Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response
2024 · Tiwadayo Braimoh, Esteban Burrone, et al. · Globalization and Health · 12
Voluntary licensing of long‐acting HIV prevention and treatment regimens: using a proven collaboration‐ and competition‐based mechanism to rapidly expand at‐scale, sustainable, quality‐assured and affordable supplies in LMICs
2023 · Lobna Gaayeb, Aditi Das, et al. · Journal of the International AIDS Society · 10
PDF
Patent Pooling In Public Health
2018 · Esteban Burrone · Cambridge University Press eBooks · 5
The case for a global therapeutics development coalition: Building a therapeutics pipeline for pandemic and endemic diseases
2024 · Shingai Machingaidze, Carmen Pérez Casas, et al. · PLOS Global Public Health · 2
Ensuring new medicines reach those in most need
2015 · Esteban Burrone, Greg Perry · The Lancet HIV · 2
Economic modelling to inform pricing for LMICs of immune checkpoint inhibitors in advanced PD-L1-high non-small cell lung cancer.
2025 · Giulia Segafredo, Dario Trapani, et al. · Journal of Clinical Oncology · 1
Estimating the return on investment of public health voluntary intellectual property licensing
2026 · Sébastien Morin, Ruth Foley, et al. · Research Square
Public health voluntary intellectual property licensing demonstrates outstanding return on investment
2026 · Sébastien Morin, Ruth Foley, et al. · Research Square
PDF
Medicines Patent Pool Voluntary Licensing Return on Investment Model
2026 · Morin, Sébastien, Foley, Ruth, et al. · Zenodo (CERN European Organization for Nuclear Research)
2317P Assessing the cost-effective price-range for pembrolizumab in treating PD-L1–high advanced non-small cell lung cancer (NSCLC) in South Africa
2025 · D. Trapani, P. Ruff, et al. · Annals of Oncology
Chapter 05 - Patent Pooling in Public Health
2018 · Esteban Burrone · eYLS (Yale Law School)
scale-up can benefi t from the best medicines available. This is one path to sustaining today's treatment gains and to meeting future goals for eradication.
2015 · Esteban Burrone, Greg Perry
การบังคับใช้สิทธิในยามะเร็ง กรณีศึกษาจากประเทศอินเดีย และการให้สิทธิในสิทธิบัตรโดยสมัครใจ กรณีศึกษา Medicines Patent Pool, ข้อดีข้อเสียต่อประเทศกําลังพัฒนาและประเทศไทย
2015 · K.S Kardam, Kajal Bhardwaj, et al.
Works count: 21
Citation count: 396
H-index: 10
I10-index: 10
Year
Topic
Type